The order carried out as a part of the project titled:
IBD: „PRE-CLINICAL AND CLINICAL RESEARCH OF CANDIDATE FOR INNOVATIVE DRUG IN ASTHMA AND INFLAMMATORY BOWEL DISEASES THERAPY” (POIR.01.01.01 00-0168/15)
IPF: DEVELOPMENT OF A FIRST-IN-CLASS SMALL MOLECULE DRUG CANDIDATE FOR TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS THROUGH CHITOTRIOSIDASE INHIBITION (POIR.01.01.01-00-0551/15)
YKL-40: Development of a first-in-class small molecule drug candidate for cancer treatment through YKL40 inhibition (POIR.01.01.01-00-0552/16)
co-financed by the European Union Funds and because of the competitiveness principle. We hereby look for Contractor ready to perform the service:
Delivery of the chemical reagent – the building block for the synthesis of chitotriosidase inhibitors.